Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gimme Care vs LIV by WellNow

Gimme Care
Graded #23

Higher grade

vs+21.699999999999996
LIV by WellNow
Graded #262

Lower grade

The verdict

Gimme Care takes it — 84.6/100 to 62.9/100.

Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($130/$163), verified, and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGimme Care +38
89
51
Dose & formulationGimme Care +7
80
73
Clinical oversightGimme Care +5
84
79
Labs & monitoringGimme Care +30
82
52
FulfillmentGimme Care +24
87
63
Contract termsGimme Care +30
85
55
Gimme Care · left barLIV by WellNow · right bar

The numbers

MetricGimme CareLIV by WellNow
WeighScore84.6/10062.9/100
GradeBC
Scorecard rank#23#262
Semaglutide$130/mo$279/mo
Tirzepatide$163/moNot disclosed
CoverageAll 50 states5 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Gimme Care

Graded #23 · B

Strengths

  • $130 sema / $163 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Not the cheapest tier
  • Injection-only
  • Monitoring detail limited
LIV by WellNow

Graded #262 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard